CEO Caitlin Zulla was paid $19,468,208 in fiscal year 2025 (SEC filing 0001193125-26-187316 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$19,468,208 Caitlin Zulla total, FY2025 | — CEO pay percentile vs peers | — CEO-to-median pay ratio | — Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
LMRI's next annual pay disclosure, estimated April 28, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Caitlin Zulla | $750,000 | $3,500,000 | $5,430,782 | $9,022,219 | $750,000 | $0 | $0 | $19,468,208 |
| Chief Executive Officer | ||||||||
| Tony Martin | 590,000 | — | 2,427,837 | 4,210,361 | 590,000 | — | — | 7,838,736 |
| Chief Financial Officer | ||||||||
| Julie Szeker | 450,000 | 1,750,000 | 2,095,813 | 663,466 | 0 | — | 15,505 | 4,995,322 |
| Former Chief Legal Officer and Corporate Secretary | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Caitlin Zulla | $19,468,208 | — | — | — |
| Tony Martin | 7,838,736 | — | — | — |
| Julie Szeker | 4,995,322 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read Lumexa Imaging Holdings's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper LMRI reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
How we handle your data → Privacy
This is the complete answer, not a partial one — the list is never padded.
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| Ann Pumpian | Independent Director | $80,000 |
| Brett Brodnax | Independent Director | $591,250 |
| Brian Regan | Independent Director | — |
| Bridget Karlin | Independent Director | $183,000 |
| Christian Rice | Director | — |
| David Jeck | Independent Director | — |
| Glenn Eisenberg | Independent Director | $183,000 |
| Jon Fromke, MD | Director | — |
| Lee Cooper | Chair of the Board | — |
| Matthew Lungren, MD | Independent Director | $117,167 |
| Molly Joseph | Lead Independent Director | $650,000 |
| Rasu Shrestha | Director | — |
| Robert Mittl, MD | Director | — |
| Sean Bryant, MD | Director | — |
No insider equity transactions reported since the proxy statement.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Tony Martin | Option | 388,888 | 18.5 | — |
| Julie Szeker | RSU | 81,081 | — | 1,500,000 |
| Caitlin Zulla | RSU | 64,864 | — | 1,199,984 |
| Caitlin Zulla | PSU | 64,864 | — | 1,199,984 |
| Tony Martin | RSU | 27,027 | — | 500,000 |
| Tony Martin | PSU | 27,027 | — | 500,000 |
| Julie Szeker | PSU | 11,876 | — | 219,706 |
| Caitlin Zulla | Option | 833,333 | 18.5 | — |
| Julie Szeker | Option | 13,333 | 18.5 | — |
| Julie Szeker | Option | 63,887 | 18.5 | — |
Our executive compensation program is intended to align executive compensation with our business objectives and to enable us to attract, retain and reward executive officers who contribute to our long-term success.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | F.W. Cook |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | — |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-10 | — | — | — | — | — |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-10 | —a |
a. Voting standard not stated in the filing.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Lee CooperNot independent · Board Chair | $5,150,000 | $0 | — | — | — | $5,150,000 |
| Molly JosephIndependent · Lead Independent Director · Audit · Nominating and Corporate Governance (Chair) | 150,000 | 500,000 | — | — | — | 650,000 |
| Brett BrodnaxIndependent · Compensation (Chair) · Nominating and Corporate Governance · Patient Safety and Quality of Care | 91,250 | 500,000 | — | — | — | 591,250 |
| Glenn EisenbergIndependent · Audit (Chair) · Compensation | 95,000 | 88,000 | — | — | — | 183,000 |
| Bridget KarlinIndependent · Audit · Technology (Chair) | 95,000 | 88,000 | — | — | — | 183,000 |
| Matthew Lungren, MDIndependent · Technology · Patient Safety and Quality of Care (Chair) | 29,167 | 88,000 | — | — | — | 117,167 |
| Ann PumpianIndependent | 80,000 | 0 | — | — | — | 80,000 |
| Christian RiceNot independent | 0 | 0 | — | — | — | 0 |
| Robert Mittl, MDNot independent · Technology · Patient Safety and Quality of Care | 0 | 0 | — | — | — | 0 |
| Sean Bryant, MDNot independent | 0 | 0 | — | — | — | 0 |
| Rasu ShresthaNot independent | 0 | 0 | — | — | — | 0 |
| David JeckIndependent | 0 | 0 | — | — | — | 0 |
| Brian ReganIndependent · Compensation · Nominating and Corporate Governance | 0 | 0 | — | — | — | 0 |
| Jon Fromke, MDNot independent | 0 | 0 | — | — | — | 0 |
| Caitlin ZullaEmployee director | — | — | — | — | — | 0 |
| Annual cash retainer | $85,000 |
|---|---|
| Annual equity retainer | $175,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 / 15,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $5,690,417 |
| Equity awards (grant-date value) | $1,264,000 |
| All other compensation | $0 |
| Total cost of the board | $6,954,417 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Lumexa Imaging Holdings | 2025 | Caitlin Zulla | $750,000 | $5,430,782 | $9,022,219 | $750,000 | $19,468,208 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Caitlin Zulla | DEF 14A | 2026-04-28 | 0001193125-26-187316 | Section “Executive Compensation”. As printed: 19,468,208. Filing ↗machine: r2 · c27 · span 240803–240813 |
| 2 | Section 01, Tony Martin | DEF 14A | 2026-04-28 | 0001193125-26-187316 | Section “Executive Compensation”. As printed: 7,838,736. Filing ↗ |
| 3 | Section 01, Julie Szeker | DEF 14A | 2026-04-28 | 0001193125-26-187316 | Section “Executive Compensation”. As printed: 4,995,322. Filing ↗ |
| 4 | Section 08, Lee Cooper | DEF 14A | 2026-04-28 | 0001193125-26-187316 | Section “Director Compensation”. As printed: 5,150,000. Filing ↗machine: span 193013–193022 |
| 5 | Section 08, Molly Joseph | DEF 14A | 2026-04-28 | 0001193125-26-187316 | Section “Director Compensation”. As printed: 650,000. Filing ↗machine: span 198254–198299 |
| 6 | Section 08, Brett Brodnax | DEF 14A | 2026-04-28 | 0001193125-26-187316 | Section “Director Compensation”. As printed: 591,250. Filing ↗machine: span 191324–191331 |
| 7 | Section 08, Glenn Eisenberg | DEF 14A | 2026-04-28 | 0001193125-26-187316 | Section “Director Compensation”. As printed: 183,000. Filing ↗machine: span 194768–194813 |
| 8 | Section 08, Bridget Karlin | DEF 14A | 2026-04-28 | 0001193125-26-187316 | Section “Director Compensation”. As printed: 183,000. Filing ↗machine: span 199436–199481 |
| 9 | Section 08, Matthew Lungren, MD | DEF 14A | 2026-04-28 | 0001193125-26-187316 | Section “Director Compensation”. As printed: 117,167. Filing ↗machine: span 200648–200693 |
| 10 | Section 08, Ann Pumpian | DEF 14A | 2026-04-28 | 0001193125-26-187316 | Section “Director Compensation”. As printed: 80,000. Filing ↗machine: span 202415–202421 |
| 11 | Section 08, Christian Rice | DEF 14A | 2026-04-28 | 0001193125-26-187316 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 12 | Section 08, Robert Mittl, MD | DEF 14A | 2026-04-28 | 0001193125-26-187316 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 13 | Section 08, Sean Bryant, MD | DEF 14A | 2026-04-28 | 0001193125-26-187316 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 14 | Section 08, Rasu Shrestha | DEF 14A | 2026-04-28 | 0001193125-26-187316 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 15 | Section 08, David Jeck | DEF 14A | 2026-04-28 | 0001193125-26-187316 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 16 | Section 08, Brian Regan | DEF 14A | 2026-04-28 | 0001193125-26-187316 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 17 | Section 08, Jon Fromke, MD | DEF 14A | 2026-04-28 | 0001193125-26-187316 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 18 | Section 08, Caitlin Zulla | DEF 14A | 2026-04-28 | 0001193125-26-187316 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 19 | Section 06, 2026 vote | Form 8-K | 2026-06-12 | 0001193125-26-269379 | Item 5.07 · say-on-pay result. As reported: —. Filing ↗ |
| 20 | Section 09b board cost (computed) | Computed | — | — | Cash 5,690,417 + equity 1,264,000 + all other 0 = 6,954,417, summed across the director compensation table rows.machine: formula: Σ = 6,954,417 |
| 21 | Lumexa Imaging Holdings (subject), Section 10b CEO total | DEF 14A | 2026-04-28 | 0001193125-26-187316 | CEO total compensation as printed in Lumexa Imaging Holdings's own proxy. As printed: 19,468,208. Filing ↗machine: r2 · c27 · span 240803–240813 |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.